Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorEXACT Therapeutics AS
About this trial
The purpose of the study is to assess the efficacy and safety of Acoustic Cluster Therapy (ACT) when given in addition to chemotherapy for treatment of Locally Advanced Pancreatic Cancer.
Eligibility criteria
Qualifiers
Not deemed suitable for primary curative surgery and have radiographic and pathological disease consistent with inoperable LAPC or borderline resectable pancreatic cancer.
Suitable to receive treatment with mFOLFIRINOX according to the Investigator's assessment.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Acoustic Cluster Therapy
- Modified FOLFIRINOX
Treatment groups
25 Participants
are divided into 1 treatment groupLocations
10United Kingdom
CAMBRIDGE CANCER TRIALS CENTRE-Addenbrooke's HospitalCB2 0QQ, CambridgeCambridge, United Kingdom
Gary Weston Centre- Imperial College Healthcare- Du Cane RoadW12 0HS, HammersmithLondon, United Kingdom
The Royal Marsden- Downs RoadSM2 5PT, SuttonSurrey, United Kingdom
United States
Arizona
HonorHealth Research Institute85258, Scottsdale United States
Sponsors and collaborators
EXACT Therapeutics AS
Lead sponsor
Source ClinicalTrials.gov